Maven Ventures

Maven Ventures is a San Francisco-based seed-stage venture firm that has quietly assembled one of consumer software's most remarkable track records. Since co-founding in 2013, the firm has backed roughly 50 companies and produced 4 IPOs, 10 acquisitions, and 7 unicorns—including stakes in Zoom (whose Series A they joined in 2013, before the $16B 2019 IPO), Embark Trucks (seed 2015, $4.5B Nasdaq debut in 2021), and a string of AI-era winners like Perplexity and xAI.

The firm's founding managing partner Jim Scheinman is known in Silicon Valley for more than dealmaking—he personally named Zoom, a prescient call that helped shape the firm's reputation as a pattern-recognizer in consumer behavior shifts before they go mainstream.

Maven's investment thesis is specific: seed-stage software startups that tap into new consumer behavior and trends. The firm looks for bold technical founders—often with a product or engineering background—who are building around shifts in how people live, work, and care for themselves and their families.

The typical engagement starts with a $1M seed check and includes a commitment to follow on at subsequent rounds for companies that hit their milestones. Maven prefers to lead or co-lead, ensuring they can be true partners to founders through the chaos of early-stage growth.

For founders considering Maven, the firm's portfolio offers a useful lens: Hello Heart (digital health for heart disease), Epic! (children's content, acquired by Byju's for $500M), Kinside (childcare benefits, acquired by UrbanSitter in 2025), May Mobility (autonomous vehicles, unicorn with $105M Series D), WildType (lab-grown salmon, $100M Series B), and Carrot Fertility all share a common thread—consumer-facing software addressing big, emotionally resonant life moments.

Maven Ventures is explicit about what it looks for: seed-stage software companies addressing emerging consumer behavior shifts. This is not a broad thematic fund—every investment maps to a recognizable trend in how people behave, raise families, care for their health, or interact with AI.

The firm's five current focus areas are Consumer AI (xAI, Perplexity, The Bot Company), Healthcare AI (Medeloop, Ease Health), Personalized Medicine (Hello Heart, Nest Genomics, Carrot Fertility), Future of Families (Kinside, Epic!, Daybreak Health), and Climate & Sustainability (Embark, WildType, QuitCarbon). Within these buckets, Maven is sector-agnostic on the specific use case—the thesis is the behavior shift, not the vertical.

Maven prefers technical founders. The firm has backed engineers, researchers, and domain experts who build the product themselves rather than just direct it. This is a meaningful signal: it suggests Maven's diligence includes technical due diligence on the founding team's ability to execute, not just the pitch.

The $1M seed check is structured as a partnership entry point. Maven explicitly states it considers follow-on investment at Series A and beyond for companies that execute. This changes the founder calculus—no round feels like a one-shot, and Maven has an incentive to help companies clear Series A hurdles.

Unlike growth-stage funds that load up on metrics, Maven's seed diligence is largely qualitative: Is the founder the right person to solve this problem? Is the timing right for this behavior shift? Is there a product insight that competitors don't yet see? The emphasis on founder depth over initial traction is typical of seed-stage VCs, but Maven's founder-first orientation is notably rigorous.

Maven's 2024 and 2025 activity reflects a clear pivot toward AI-native consumer products. The firm led or participated in rounds for xAI, Perplexity, The Bot Company, and MultiOn—all consumer AI bets placed before those companies became widely recognized as category leaders.

In 2023 and 2024, Maven also backed Medeloop (healthcare AI, $8M seed), Lutra (AI workflows), Gondola (travel AI), and QuitCarbon (home electrification cleantech). The common thread: AI applied to real consumer pain points rather than infrastructure or enterprise productivity tools.

The firm's geographic footprint remains centered on the US, with occasional international bets. Its Los Altos office location puts it squarely in the Bay Area founder network, where most deal flow originates through warm introductions from existing portfolio founders or tier-one investor networks.

On the exit side, recent activity includes Kinside's acquisition by UrbanSitter in 2025 and the ongoing pre-IPO positioning of Wealthfront, which has publicly discussed a 2026 IPO. May Mobility continues its path toward a potential public offering as an autonomous vehicle operator with real revenue.

Maven has not dramatically shifted its deployment pace despite market softness. The firm remains a consistent seed investor with a reputation for moving quickly on companies that fit its thesis—a critical attribute for founders who need certainty of capital during intense competition for top deals.

Zoom remains Maven's signature win. The firm participated in Zoom's Series A in 2013—back when video conferencing was still a niche enterprise tool—and held through the 2019 IPO that valued the company at $16B at debut. Jim Scheinman's personal role in naming the company is a founding myth that Maven leans on credibly when pitching founder-friendly partnership.

Embark Trucks is Maven's second-largest known success. The firm took a seed position in 2015, and Embark IPO'd on Nasdaq in 2021 at a $4.5B valuation. The company was later acquired by Applied Intuition in 2023, but the public-market debut validated Maven's early conviction in autonomous trucking.

May Mobility illustrates Maven's willingness to bet on capital-intensive AV infrastructure. The firm has backed May Mobility since 2017, and the company reached unicorn status after a $105M Series D—a remarkable trajectory for a fleet autonomy player that chose to focus on operational deployment over speculative technology.

On the consumer AI front, xAI (Elon Musk's AI venture), Perplexity (AI search), and The Bot Company (consumer AI/robotics) represent Maven's highest-profile current holdings. None have exited, but the concentration in this space signals Maven's view that the next generation of consumer software is AI-native and behavior-first.

Hello Heart, the digital health platform focused on heart disease monitoring, is notable for its $70M Series D and its positioning in a market—chronic disease management—that has proven durable through multiple market cycles. Similarly, Carrot Fertility's trajectory from seed to established benefits platform shows Maven's eye for life-stage consumer needs.

The acquisition track record is also worth noting: Cruise (acquired by GM for ~$1B in 2016), Epic! (acquired by Byju's for $500M in 2021), Docket (acquired by Zoom in 2022), Gennev (acquired in 2022), and Kinside (acquired by UrbanSitter in 2025) all represent exits that provided liquidity for founders and early investors within 5-8 years of seed investment.

Founder depth is non-negotiable at Maven. The firm looks for technical backgrounds, genuine domain expertise built through lived experience, and evidence that the founder has thought more deeply about the problem space than anyone else in the room. References matter—a founder who comes recommended by a previous employer or collaborator who can speak to their execution ability is significantly more likely to get a meeting.

The behavior-shift lens is the clearest filter. Maven asks: is the founder building around a genuine shift in how consumers behave, or are they incremental improvements to existing behavior? The distinction matters because incremental products compete on distribution, and distribution is not a seed-stage company's advantage.

Product originality is evaluated rigorously. Maven has seen thousands of pitches in its focus areas and uses that pattern recognition to quickly identify derivative thinking. Founders who can articulate a counterfactual—here is what the category looked like before my product, here is what it looks like after—are more compelling than those who simply claim to be better.

TAM analysis at seed stage is acknowledged as inherently uncertain, but Maven still expects founders to have done the work. The firm will probe whether the founder has considered adjacent markets, competitive responses, and the specific customer segment they are targeting before expanding. A founder who can say 'we are starting here and expanding here' is more credible than one who claims to address a $100B market from day one.

Maven's preference for companies with a clear path to product-market fit—even if early—is another consistent theme. Metrics matter less than evidence of compounding growth: whether that's retention curves, NPS trends, or organic word-of-mouth. A founder who can show one channel working exceptionally well before scaling is more convincing than one showing broad but shallow adoption.

Warm introductions from Maven's portfolio founders are by far the highest-conversion path into a first meeting. The firm has a loyal founder base—many of whom reinvest or refer—and a warm intro from someone like a Hello Heart or May Mobility founder will get immediate attention. Building genuine relationships with Maven's portfolio before pitching is the most credible approach.

If a warm intro is not available, the second-best path is a reference from a trusted investor who has co-invested with Maven before. The firm has strong relationships with a network of seed funds and angels, and a referral from that network carries real weight.

Cold outreach to Maven through their website (mavenventures.com) is less effective but still viable, particularly if the company is clearly in one of Maven's focus areas and has a founding team with a strong technical background. The email should be short, specific, and immediately relevant to Maven's stated thesis.

Once a meeting is secured, Maven's diligence process typically runs 2-4 weeks from initial meeting to term sheet for companies that pass the first screen. The firm moves quickly compared to many seed funds, which is a meaningful advantage in competitive processes.

Following up after a meeting without being pushy is important. Maven's partnership reviews opportunities together, and sending a concise update on milestones achieved after the meeting keeps the conversation warm without creating pressure. Significant news—a major customer signing, a product launch, a key hire—is appropriate to share proactively.

Building a relationship with Maven over time is genuinely valuable even if the current round does not result in an investment. The firm has a strong referral network, and founders who impress Maven often get introduced to other investors who are a better fit for their stage or sector.

Maven invests at seed stage, where financial history is often thin or nonexistent. But that does not mean founders should come unprepared. The firm expects founders to understand their SaaS unit economics at a conceptual level—even if the numbers are early—because it signals the intellectual honesty that will be needed when the company scales.

Key preparations include a clear narrative of how capital will be deployed to reach measurable milestones, an honest burn rate and runway calculation, and a defensible view of what the Series A metrics will need to look like. Maven will probe these assumptions, and a founder who has done the modeling work will answer more confidently.

For consumer software companies, cohort-level retention data is often the most persuasive metric. Maven's partners have seen enough consumer companies to know the difference between a product with real retention and one with inflated top-line numbers. Cohort charts showing declining churn over time are more compelling than monthly active user graphs.

Working with a fractional CFO is especially useful for first-time founders who are strong on product but less experienced on financial modeling. A fractional CFO can help translate the business model into investor-ready language, build scenario models for different growth paths, and prepare the founder for the rigorous financial Q&A that marks serious venture diligence.

Our team has helped seed-stage companies across Maven's focus areas prepare for venture diligence. From building financial models that survive Maven's scrutiny to preparing board-level projections for post-raise governance, we ensure founders are confident and credible in every financial conversation.

Financial clarity is a competitive advantage in seed fundraising. Founders who can speak fluently about their metrics, model their growth scenarios with rigor, and explain how additional capital translates into milestones are more likely to earn Maven's conviction than those who rely solely on a compelling narrative.

Exploring other venture capital firms? Our comprehensive collection of VC firm reviews covers hundreds of investors across all stages and sectors.

Each review provides detailed information about investment criteria, portfolio companies, and tips for securing funding. Whether you are looking for seed-stage investors or growth equity firms, you will find valuable insights in our VC firm guides.

Finding the right investor for your startup is crucial to your success. Take the time to research potential investors and understand their investment thesis before reaching out.

Our guides cover major venture capital firms as well as emerging managers that may be a better fit for your company's specific needs and stage.